Picato (ingenol Mebutate Gel, 0.015% And 0.05%) - Product Withdrawal In Canada Due To Potential Increased Risk Of Skin Cancer

Picato Recall Summary Picato (ingenol mebutate gel) is being withdrawn from the Canadian market because of a potential increased risk of skin cancer. The product was distributed across Canada and is used to treat certain skin conditions. Health authorities determined the safety risk outweighs the benefits of the medication.

Reason

Product safety

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2020-10-27

Status

Ongoing

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/be94676a-720b-4590-94a4-9de7f86f696a